Drug Approval | November 27, 2025
SMS Pharmaceutical's associate company receives FDA approval for reformulated Ranitidine
The approval by the US FDA comes after extensive safety testing and manufacturing improvements
The approval by the US FDA comes after extensive safety testing and manufacturing improvements
Scientific consensus is that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer and GSK will continue to vigorously defend itself against all claims
N-nitroso dimethylamine (NDMA) is a probable human carcinogen and tts effects on humans rely on observational studies.
Ranitidine Hydrochloride is an important product for Solara and is manufactured at its Cuddalore site
Marksans' OTC Famotidine Tablets USP are acid reducers
The current ruling will assure the safety of the use of Ranitidine for Indian patients
GSKP announced sale of its newly constructed manufacturing plant at Vemgal, Karnataka to Hetero Labs for a cash consideration of Rs1.8bn
Subscribe To Our Newsletter & Stay Updated
